CTRI/2017/10/009960已完成未知
Monitoring Adverse Drug Reactions Of Pemetrexed Platinum Doublet Chemotherapy in patients with non-squamous non-small cell lung cancer or mesothelioma in Tata Memorial Centre - ADR-NSCLC
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- A
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Patients with histologically confirmed NSCLC or mesothelioma
- •2. Patients receiving first cycle of Pemtrexed + Platinum Doublet Chemotherapy
排除标准
- •Patients having non-compliance to treatment schedule at Tata Memorial Centre
- •Patients not willing to give written informed consent
研究者
相似试验
已完成
不适用
Comparison of two chemotherapeutic drug combinations for lung cancer.CTRI/2019/05/019130Government medical college hospital Trivandrum151
招募中
2 期
Phase II study of Combination Therapy of Pemetrexed/Carboplatin/Bevacizumab for Advanced Non-small-cell lung cancernon-squamous non-small-cell lung cancerJPRN-UMIN000004685ational Hospital Organization Hokkaido Medical Center38
已完成
2 期
A Phase II Study of Pemetrexed in chemo-naive Elderly Patients with Lung Adenocarcinoma and An exploratory study on Mechanisms of chemotherapy resistance.Previously untreated lung adenocarcinomaJPRN-UMIN000006113Division of Respirology, department of internal medicine, Jikei University Hospital32
招募中
不适用
Study of pemetrexed in previously-treated patients with advanced squamous cell lung carcinoma having low level of TSKCT0003518CC Hospital32
招募中
2 期
Phase II Study of Pemetrexed in Combination with Carboplatin Followed by Pemetrexed Maintenance Therapy for Elderly Advanced Non-squamous and Non-small Cell Lung Cancer.on-squamous non-small-cell lung cancerJPRN-UMIN000006139Tochigi Thoracic Oncology Research Organization50